
On the third day of the third quarter, Cardinal Capital, a name that had once carried the weight of empires in the world of finance, divested itself of a portion of Brookfield. The sale, cloaked in the bureaucratic fog of SEC filings, left behind a trail of numbers: 44,619 shares, $2.92 million, and a remaining stake of 2,164,145 shares, now valued at $148.58 million. The wind carried the shares like autumn leaves, and the market, ever the scribe, noted that Brookfield’s position had shrunk to 4.3% of Cardinal’s reportable assets-a reduction as quiet as the closing of a ledger in a forgotten vault.